← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $811K of BioMarin Pharmaceutical Inc.

Sold$810,550
$90.06Price
9,000Shares
−2%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Mon, Mar 11. Filed Wed, Mar 13, 8:00 PM ET, after the close. Not investment advice.